Graeme McFarlane
Chief Commercial Officer (CCO) at Albert Labs- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Albert Labs
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Commercial Officer (CCO)
-
Sep 2020 - Present
Albert Labs is a laboratory based, clinical research and drug development enterprise, very much with the scientific behaviours of a Biotech company, focused on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways and early access schemes. The company’s core focus is treating patients with urgent and unmet needs; these are critical mental health indications, that are not being addressed by big pharma, beginning with cancer-related distress - anxiety, depression and existential crises initially through trials in the UK and Scandinavia.
-
-
-
CBD Science Group PLC
-
Health, Wellness & Fitness
-
Chief Commercial Officer
-
Apr 2019 - Present
CBD Science Group is focused on bringing pharma grade medicinal cannabis to market to provide clinically proven solutions in an area of national agenda focus and currently an 'unmet need' - cancer related chronic pain. Our plans include launching a rigorous clinical trial in the 'real-world' setting providing early access for patients and clinical proof as to the advantages derived form our medicinal cannabis treatment. CBD Science Group is focused on bringing pharma grade medicinal cannabis to market to provide clinically proven solutions in an area of national agenda focus and currently an 'unmet need' - cancer related chronic pain. Our plans include launching a rigorous clinical trial in the 'real-world' setting providing early access for patients and clinical proof as to the advantages derived form our medicinal cannabis treatment.
-
-